Dr. Bill Levine is a serial entrepreneur. He initially founded Izun Pharmaceuticals Corporation, a biopharmaceutical company specializing in Botanical Medicine. This area of specialty pharma develops pharmaceutical and healthcare products from plant based sources. Bill, who received his DDS degree and specialty training in Periodontics from Columbia University initially utilized this background to formulate novel oral care products to treat periodontal disease more effectively. This company was recently spun off, raised funds and is seeking an IPO in early 2017. Izun has also developed wound care, and oncology support products. Subsequently, recognizing the Izun expertise in botanicals, Bill applied this knowledge to the cannabis plant and established CannRx. In a short time span, CannRx has developed validated assays (receiving ISO 172005 laboratory certification), new and differentiated delivery systems, identified & licensed new potent strains and appears well on its way to establishing itself as a leading player in the cannabis field.